Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients

Leuk Lymphoma. 2019 Aug;60(8):2067-2070. doi: 10.1080/10428194.2018.1564048. Epub 2019 Jan 22.

Authors

Marcello Riva¹, Federica Lessi¹, Tamara Berno¹, Andrea Visentin¹, Marta Campagnolo², Gianpietro Semenzato¹, Fausto Adami¹, Chiara Briani²

Affiliations

¹ a Haematology and Clinical Immunology Unit, Department of Medicine , University of Padova Padova , Italy.
² b Neurology Unit, Department of Neuroscience , University of Padova , Padova , Italy.

PMID: 30668203
DOI: 10.1080/10428194.2018.1564048

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biomarkers
Bortezomib / administration & dosage
Female
Humans
Male
Middle Aged
POEMS Syndrome / diagnosis
POEMS Syndrome / drug therapy*
POEMS Syndrome / etiology
Positron Emission Tomography Computed Tomography
Treatment Outcome

Substances

Biomarkers
Bortezomib